XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D208. A total of 4 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $82,000 | -33.3% | 129,811 | 0.0% | 0.00% | – |
| Q3 2016 | $123,000 | -18.5% | 129,811 | 0.0% | 0.00% | – |
| Q2 2016 | $151,000 | +12.7% | 129,811 | 0.0% | 0.00% | – |
| Q1 2016 | $134,000 | -26.8% | 129,811 | 0.0% | 0.00% | – |
| Q4 2015 | $183,000 | -9.9% | 129,811 | 0.0% | 0.00% | – |
| Q3 2015 | $203,000 | -16.5% | 129,811 | 0.0% | 0.00% | – |
| Q2 2015 | $243,000 | -18.7% | 129,811 | 0.0% | 0.00% | – |
| Q1 2015 | $299,000 | +16.3% | 129,811 | 0.0% | 0.00% | – |
| Q4 2014 | $257,000 | +16.3% | 129,811 | 0.0% | 0.00% | – |
| Q3 2014 | $221,000 | -44.3% | 129,811 | 0.0% | 0.00% | – |
| Q2 2014 | $397,000 | -16.1% | 129,811 | 0.0% | 0.00% | – |
| Q1 2014 | $473,000 | +25.8% | 129,811 | 0.0% | 0.00% | – |
| Q4 2013 | $376,000 | -45.7% | 129,811 | 0.0% | 0.00% | – |
| Q3 2013 | $692,000 | – | 129,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 1,574 | $3,000 | 0.00% |
| MORGAN STANLEY | 4 | $0 | 0.00% |
| Invesco Ltd. | 129,811 | $257,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,026 | $2,000 | 0.00% |